Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors

Stopped early · Phase 2

Conditions studied: Head and Neck Cancer, Islet Cell Tumor, Metastatic Cancer, Pheochromocytoma

In brief

RATIONALE: Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. PURPOSE: This phase II trial is studying how well internal radiation therapy works in treating patients with liver metastases from neuroendocrine tumors.

Key facts

Study ID

NCT00466856

Run by

Vanderbilt-Ingram Cancer Center

People needed

10

Starts

2003-12-01

Expected to finish

2007-10-01

Last updated by the study team

2012-05-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Vanderbilt-Ingram Cancer Center — Nashville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.